FIŞA DE VERIFICARE
a îndeplinirii standardelor minimale în vederea obţinerii atestatului de abilitare
în cadrul I.O.S.U.D. Universitatea Titu Maiorescu, Bucureşti
Domeniile de doctorat: Medicină
I. Date despre candidat
Nume: Sîrbu
Prenume: Carmen Adella
1. Doctor în ştiinţe
X□ DA □ NU
„Hidatidoza cerebrala”,
Conducător ştiinţific Prof.dr Simona Radulescu (2004), UMF Carol Davila
Bucuresti, seria D/0003025, nr 1725/09.XII.2004
Ordinul de confirmare: 4450 din 2 august 2004
2. Medic/ medic dentist/farmacist primar în specialitatea postului (la disciplinele cu
corespondent în reţeaua Ministerului Sănătăţii)
X□ DA □ NU
Ordinul de confirmare: 1067/2004 pe baza examenului susținut în sesiunea iunie
2004 și promovat cu media generală 9,77 (medic primar neurolog)
II. Date numerice privind îndeplinirea standardelor minimale naţionale, conform anexelor nr.
20 şi 23 ale Ordinului Ministrului Educaţiei Naţionale şi Cercetării Ştiinţifice nr.
6129/20.12.2016
1. Articole publicate în reviste cotate ISI în calitate de autor principal
Criteriul Standard minim Realizat
Număr articole publicate în
reviste cotate ISI în calitate
de autor principal
10 12
Criteriu îndeplinit:
X□ DA □ NU
Lista articolelor ISI publicate în calitate de autor principal: autori, titlu articol, revistă, an,
volum, pagini, factor de impact:
AP1. Sirbu, C.A.; Dantes, E.; Plesa, C.F.; Docu Axelerad, A.; Ghinescu, M.C. Active
Pulmonary Tuberculosis Triggered by Interferon Beta-1b Therapy of Multiple Sclerosis: Four
Case Reports and a Literature Review (Review). Medicina-Lithuania, 2020; 56 (202):1-7.
doi.org/10.3390/medicina56040202, FI= 1,467.
AP2. Sirbu CA, Mezei RM, Falup‑Pecurariu C, Bratu OG, Sirbu AM, Ghinescu MC, Ionita
Radu F. Autonomic dysfunctions in multiple sclerosis: Challenges of clinical practice
(Review). Exp. Ther. Med 20: 196, 2020, Published online on: 14 octombrie 2020,
https://doi.org/10.3892/etm.2020.9326, IF=1,785
AP3. Sîrbu OM, Chirteş AV, Mitricã M, Sîrbu CA. Spinal Intramedullary Epidermoid Cyst:
Case Report and Updated Literature Review. World Neurosurg. 2020;139:39‐50.
DOI: https://doi.org/10.1016/j.wneu.2020.03.207, FI=1,723.
AP4. Sirbu CA, Florea AA, Ghinescu MC, Docu‑Axelerad A, Sirbu AM, Bratu OG, Ionita
Radu F. Vaccination in multiple sclerosis ‑ Challenging practices (Review). Exp. Ther. Med
20: 217, 2020. Published online on: October 15, 2020 https://doi.org/10.3892/etm.2020.9347,
IF=1,785
AP5. Sirbu CA, Budisteanu M, Falup-Pecurariu C. Monoclonal antibodies - a revolutionary
therapy in multiple sclerosis. Neurol Neurochir Pol. 2020;54(1):21‐27.
DOI: 10.5603/PJNNS.a2020.0008 , IF=1,006.
AP6. Sirbu CA, Plesa FC, Ghinescu MC, Caloianu I, Ionita-Radu F, Persistence on interferon
beta-1b in multiple sclerosis: 19-year of follow-up, Farmacia, 68(4): 7752-756, 2020,
https://doi.org/10.31925/farmacia.2020.4.23, IF=1,527.
AP7. Budisteanu M, Andrei E, Linca F, Hulea DS, Velicu AC, Mihailescu I, Riga S, Arghir
A, Papuc SM, Sirbu CA, Mitrica M, Docu‑Axelerad A, Ghinescu MC, Dobrescu I, Rad F.
Predictive factors in early onset schizophrenia. Exp. Ther. Med 20: 210, 2020. Published
online on: October 14, 2020 https://doi.org/10.3892/etm.2020.9340, IF=1,785 (corresponding
author).
AP8. Sîrbu CA, Drăgoi CM, Nicolae AC, Pleșa CF, History of interferon treatments in
multiple sclerosis – 60 years of progress, Farmacia, 2017, Vol. 65, 1, 14-18,
http://farmaciajournal.com/issue-articles/history-of-interferon-treatments-in-multiple-
sclerosis-60-years-of-progress/ IF=1,507
AP9. Nicolae AC, Arsene AL, Vuță V, Popa DE, Sirbu CA, Burcea-Dragomiroiu IB,
Dumitrescu GTA, Velescu BS, Gofiță E, Drăgoi CM (All authors have equal contribution) - In
vitro P-gp expression after administration of CNS active drugs, Farmacia, nr.6, 2016,vol 64,
ISSN: 2065-0019 http://www.revistafarmacia.ro/201606/issue62016art7.html, IF=1.348
AP10. Sirbu CA, Furdu-Lungut E, Plesa CF, Nicolae AC, Dragoi CM, Pharmacological
treatment of relapsing remitting multiple sclerosis-where we are throw evidence based
medicine?–review , Farmacia nr 5 2016,vol 64, 5, pag 651-655, ISSN: 2065-0019
http://www.revistafarmacia.ro/201605/issue52016art1.html IF=1.348
AP11. Sirbu CA, Sirbu OM, Constantin C, Sandu AM, Neuroimunotoxicity Of Aluminum,
Farmacia, 2015 nr.1 Vol. 63, 1, pag. 8-10, ISSN: 2065-0019
http://www.revistafarmacia.ro/201501/issue12015art2.html, IF=1.162
AP12. Sîrbu C. Arthur Kreindler (1900–1988). Journal of Neurology, 253, 965–966 (2006).
https://doi.org/10.1007/s00415-006-0939-8, IF=3,853
2. Articole publicate în reviste cotate ISI în calitate de coautor
Criteriul Standard minim Realizat
Număr articole publicate în
reviste cotate ISI în calitate
de coautor
5 9
Criteriu îndeplinit:
X □ DA □ NU
Lista articolelor ISI publicate în calitate de coautor: autori, titlu articol, revistă, an, volum,
pagini, factor de impact
CA1. Falup-Pecurariu C, Diaconu Ș, Falup-Pecurariu O, Ciopleiaș B, Sîrbu CA. Acute
reversible parkinsonism post-influenza infection. Acta Neurol Belg. 120, 723–724, 2020.
https://doi.org/10.1007/s13760-019-01215-2 , IF=1,612
CA2. Sirbu AM, Sirbu CA, Eftimie L, Soare AM, Ghinescu MC, Ionita-Radu F. Multiple
sclerosis, human herpesvirus 4 and thyroid collision tumor: A case report. Exp Ther Med.
2020 Oct;20(4):3458-3461. doi: 10.3892/etm.2020.8975. Epub 2020 Jul 7. PMID: 32905114;
PMCID: PMC7465335, IF=1,785
CA3. Strand EB, Nacul L, Mengshoel AM, Helland IB, Grabowski P, Krumina A, Alegre-
Martin J, Efrim-Budisteanu M, Sekulic S, Pheby D, Sakkas GK, Sirbu CA, Authier FJ;
European Network on ME/CFS (EUROMENE). Myalgic encephalomyelitis/chronic fatigue
Syndrome (ME/CFS): Investigating care practices pointed out to disparities in diagnosis and
treatment across European Union. PLoS One. 2019;14(12):e0225995. Published 2019 Dec 5.
https://doi.org/10.1371/journal.pone.0225995 IF=2,776
CA4. Zhou Y, Claflin SB, Stankovich J, van der Mei I, Simpson S Jr, Roxburgh RH, Kalincik
T, Blizzard L, Lugaresi A, Alroughani R, Sajedi SA, Butzkueven H, Pucci E, Spitaleri D,
Granella F, Cristiano E, Yamout B, Hughes S, Gouider R, Sánchez Menoyo JL, Olascoaga J,
McGuigan C, Shaw C, Kermode AG, Kasa K, Al-Harbi T, Altintas A, Laureys G, Fragoso Y,
Hardy TA, Csepany T, Sirbu CA, Decoo D, Sas A, Alvarez-Cermeño JC, Kotkata K, Millán-
Pascual J, Taylor BV. Redefining the Multiple Sclerosis Severity Score (MSSS):Redefining
the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype. Mult
Scler. 2019 Oct 31:1352458519881994. https://doi.org/10.1177/1352458519881994 Online ahead
of print.PMID: 31668127 , IF= 5.649
CA5. Hobart J, Bowen A, Pepper G, Crofts H, Eberhard L, Berger T, Boyko A, Boz C,
Butzkueven H, Celius EG, Drulovic J, Flores J, Horáková D, Lebrun-Frénay C, Marrie RA,
Overell J, Piehl F, Rasmussen PV, Sá MJ, Sîrbu CA, Skromne E, Torkildsen Ø, van Pesch V,
Vollmer T, Zakaria M, Ziemssen T, Giovannoni G. International consensus on quality
standards for brain health-focused care in multiple sclerosis. Mult Scler. 2019 Nov;
25(13):1809-1818. https://doi.org/10.1177/1352458518809326 Epub 2018 Nov
1.PMID: 30381987 , IF= 5.649
CA6. Kalincik T, Kuhle J, Pucci E, Rojas JI, Tsolaki M, Sirbu CA, Slee M, Butzkueven H;
MSBase Scientific Leadership Group and MSBase Study Group. Data quality evaluation for
observational multiple sclerosis registries. Mult Scler. 2017 Apr;23(5):647-655.
DOI: 10.1177/1352458516662728 Epub 2016 Aug 5.PMID: 27481209, IF = 4,840
CA7. Kalincik T, Buzzard K, Jokubaitis V, Trojano M, Duquette P, Izquierdo G, Girard M,
Lugaresi A, Grammond P, Grand'Maison F, Oreja-Guevara C, Boz C, Hupperts R, Petersen T,
Giuliani G, Iuliano G, Lechner-Scott J, Barnett M, Bergamaschi R, Van Pesch V, Amato MP,
van Munster E, Fernandez-Bolanos R, Verheul F, Fiol M, Cristiano E, Slee M, Rio ME,
Spitaleri D, Alroughani R, Gray O, Saladino ML, Flechter S, Herbert J, Cabrera-Gomez JA,
Vella N, Paine M, Shaw C, Moore F, Vucic S, Savino A, Singhal B, Petkovska-Boskova T,
Parratt J, Sirbu CA, Rozsa C, Liew D, Butzkueven H; MSBase Study Group. Risk of relapse
phenotype recurrence in multiple sclerosis.
Mult Scler. 2014 Oct;20(11):1511-22. Epub 2014 Apr 28.PMID: 24777276
DOI: 10.1177/1352458514528762, IF=4,822
CA8. Kalincik T, Vivek V, Jokubaitis V, Lechner-Scott J, Trojano M, Izquierdo G, Lugaresi
A, Grand'maison F, Hupperts R, Oreja-Guevara C, Bergamaschi R, Iuliano G, Alroughani R,
Van Pesch V, Amato MP, Slee M, Verheul F, Fernandez-Bolanos R, Fiol M, Spitaleri DL,
Cristiano E, Gray O, Cabrera-Gomez JA, Shaygannejad V, Herbert J, Vucic S, Needham M,
Petkovska-Boskova T, Sirbu CA, Duquette P, Girard M, Grammond P, Boz C, Giuliani G, Rio
ME, Barnett M, Flechter S, Moore F, Singhal B, Bacile EA, Saladino ML, Shaw C, Skromne
E, Poehlau D, Vella N, Spelman T, Liew D, Kilpatrick TJ, Butzkueven H; MSBase Study
Group. Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.
Brain. 2013 Dec;136(Pt 12):3609-17. https://doi.org/10.1093/brain/awt281 Epub 2013 Oct
18.PMID: 24142147, IF=10,226
CA9. Meyniel C, Spelman T, Jokubaitis VG, Trojano M, Izquierdo G, Grand'Maison F, Oreja-
Guevara C, Boz C, Lugaresi A, Girard M, Grammond P, Iuliano G, Fiol M, Cabrera-Gomez
JA, Fernandez-Bolanos R, Giuliani G, Lechner-Scott J, Cristiano E, Herbert J, Petkovska-
Boskova T, Bergamaschi R, van Pesch V, Moore F, Vella N, Slee M, Santiago V, Barnett M,
Havrdova E, Young C, Sirbu CA, Tanner M, Rutherford M, Butzkueven H; MSBasis Study
Group. Country, sex, EDSS change and therapy choice independently predict treatment
discontinuation in multiple sclerosis and clinically isolated syndrome. PLoS One.
2012;7(6):e38661. DOI: 10.1371/journal.pone.0038661 Epub 2012 Jun 29.PMID: 22768046 ,
IF= 3.730
3. Factorul cumulat de impact pentru articolele publicate ca autor principal în reviste
cotate ISI (FCIAP)
Criteriul Standard minim Realizat
(ISI) Factor cumulat de
impact autor principal
10 16,913
Criteriu îndeplinit:
X□ DA □ NU
4. Indexul Hirsch
Criteriul Standard minim Realizat
Index Hirsch 6 7
Criteriu îndeplinit:
X□ DA □ NU
Confirm prin prezenta că datele menționate mai sus sunt reale și se referă la propria mea
activitate profesională și științifică
Articole ISI unde sunt coautor:
Data Semnătura candidatului
23.10.2020 Conf.univ.dr.
Carmen Adella Sirbu